FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 368.80
-3.20 (-0.86%)
At close: May 5, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 60.57 billion as of May 6, 2026. Its market cap has decreased by -11.85% in one year.
Market Cap
60.57B
Enterprise Value
56.53B
Revenue
20.78B
Ranking
n/a
PE Ratio
27.97
Stock Price
368.80
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 60.57B, an increase of 2,120.81%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 60.04B | -12.88% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 146.79B |
| Caplin Point Laboratories | 130.03B |
| CORONA Remedies | 105.60B |
| Viyash Scientific | 89.10B |
| Procter & Gamble Health | 86.23B |
| Sanofi India | 78.49B |
| Bliss GVS Pharma | 29.22B |
| Gufic Biosciences | 28.60B |